524742 logo

Caplin Point Laboratories Limited Stock Price

BSE:524742 Community·₹146.3b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 13 Fair Values set on narratives written by author

524742 Share Price Performance

₹1,924.25
-61.10 (-3.08%)
₹2,508.00
Fair Value
₹1,924.25
-61.10 (-3.08%)
23.3% undervalued intrinsic discount
₹2,508.00
Fair Value
Price ₹1,924.25
AnalystConsensusTarget ₹2,508.00

524742 Community Narratives

AnalystConsensusTarget·
Fair Value ₹2.51k 23.3% undervalued intrinsic discount

Latin American Expansion And Global Scaling Will Secure Enduring Success

0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative

Snowflake Analysis

Flawless balance sheet established dividend payer.

0 Risks
5 Rewards

Caplin Point Laboratories Limited Key Details

₹20.4b

Revenue

₹8.3b

Cost of Revenue

₹12.1b

Gross Profit

₹6.2b

Other Expenses

₹5.9b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
77.46
59.21%
28.84%
0.02%
View Full Analysis

About 524742

Founded
1990
Employees
3966
CEO
Sridhar Ganesan
WebsiteView website
www.caplinpoint.net

Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry and syrups, lyophilized vials, prefilled syringes, emulsion injection, sachets, liquid injectables, topicals, pre-filled syringes, and pre-mix bags. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.

Recent 524742 News & Updates

Recent updates

No updates